Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.46+0.49 (+7.03%)
Close on Nov 18, 2026Market cap $448.38MP/E –Yield –
Orchestra BioMed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Orchestra BioMed's operating income for the twelve months ending Jun 30, 2026 was -$57.99M. For fiscal 2025 it was -$51.81M. The highest annual figure on record is -$394.76K in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$51.81M | – |
| FY2024 | Dec 31, 2024 | -$64.30M | – |
| FY2023 | Dec 31, 2023 | -$51.51M | – |
| FY2022 | Dec 31, 2022 | -$32.66M | – |
| FY2021 | Dec 31, 2021 | -$394.76K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$22.36M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.08M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$20.31M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.33M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.92M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.68M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.34M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.86M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.42M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.55M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.83M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.63M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$92.05K | – |
| Q3 FY2021 | Sep 30, 2021 | -$94.45K | – |
| Q2 FY2021 | Jun 30, 2021 | -$96.32K | – |
| Q1 FY2021 | Mar 31, 2021 | -$111.95K | – |
| Q3 FY2020 | Sep 30, 2020 | -$68.63K | – |
See a number that looks wrong?